31Phosphorus magnetic resonance spectroscopy characterization of muscular metabolic anomalies in patients with malignant hyperthermia: Application to diagnosis

Anesthesiology

Volumn 88, Issue 1, 1998, Pages 96-107

  Bendahan, David ^b   Kozak Ribbens, Geneviève ^b   Rodet, Laurence ^b   Confort Gouny, Sylviane ^b   Cozzone, Patrick J ^a  

^a University of Aix Marseille   (France)

^b NONE

Author keywords

Anesthesia; Energetics; Exercise; Muscle metabolism; Physiopathology

Indexed keywords

ADULT; ARTICLE; CALCIUM HOMEOSTASIS; CLINICAL ARTICLE; DIAGNOSTIC VALUE; DISEASE PREDISPOSITION; FEMALE; GLYCOGEN MUSCLE LEVEL; GLYCOLYSIS; HAND MUSCLE; HUMAN; MALE; MALIGNANT HYPERTHERMIA; MUSCLE METABOLISM; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RISK ASSESSMENT; EXERCISE; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RETROSPECTIVE STUDY; SKELETAL MUSCLE;

ADULT; DISEASE SUSCEPTIBILITY; EXERCISE; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MALIGNANT HYPERTHERMIA; MUSCLE, SKELETAL; RETROSPECTIVE STUDIES;

EID: 0031594138     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199801000-00017     Document Type: Article

References (26)

1. Mac Lennan DH, Phillips MS: Malignant hyperthermia. Science 1992; 296:789-94
2. Ball SP, Johnson KJ: The genetics of malignant hyperthermia. J Med Genet 1993; 30:89-93
3. Kozak-Reiss G, Gascard JP, Redouane-Benichou K: Malignant hyperthermia: Diagnostic means and the possibilities opened by NMR spectroscopy. Ann Fr Anesth Réanim 1986; 5:584-9
4. Olgin J, Argov Z, Rosenberg H, Tuchler M, Chance B: Noninvasive evaluation of malignant hyperthermia susceptibility with phosphorus nuclear magnetic resonance spectroscopy. ANESTHESIOLOGY 1988; 68:507-13
5. Olgin J, Rosenberg H, Allen G, Secstedt R, Chance B: A blinded comparison of non invasive, in vivo phosphorus nuclear magnetic resonance spectroscops and the in vitro halothane/caffeine contracture test in the evaluation of malignant hyperthermia susceptibility. Anesth Analg 1991;72:36-47
6. Webster DW, Thompson RT, Graevelle DR, Laschuk MJ, Driedger AA: Metabolic response to exercise in malignant hyperthermia-sensitive patients measured by 31-P magnetic resonance spectroscopy. Magn Reson Med 1990; 15:81-9
7. Payen JF, Bourdon L, Mezin P, Jucquot C, Le Bas JF, Stieglitz P, Benabid AL: Susceptibility to malignant hyperthermia detected non invasively. Lancet 1991; 337:1550-1
8. Payen JF, Bosson JL, Bourdon L, Jacquot C, Le Bas JF, Stieglitz P, Benabid AL: Improved noninvasive diagnostic testing for malignant hyperthermia susceptibility from a combination of metabolites determined in vivo with 31-P magnetic resonance spectroscopy. ANESTHESIOLOGY 1993; 78:848-55
9. The European Malignant Hyperpyrexia Group (EMHG): A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. Br J Anaesth 1984; 56:126-9
10. Cozzone PJ, Bendahan D: P-31 NMR spectroscopy of metabolic changes associated with muscle exercise: Physiopathological applications, NMR in Physiology and Medicine. Edited by RG Gullies. Academic Press, 1994, pp 389-403
11. Bendahan D, Confort-Gouny S, Kozak-Reiss G, Cozzone PJ: Heterogeneity of metabolic response to exercise in humans: New criteria of invariance defined by in vivo phosphorus NMR spectroscopy. FEBS Lett 1990; 272:155-8
12. Bendahan D, Confort Gouny S, Kozak Ribbens G, Cozzone PJ: Pi-trapping in glycogenolytic pathway can explain transient Pi disappearance during recovery from muscular exercise: A P-31 NMR study in the human. FEBS Letters 1990; 269:402-5
13. Moon RB, Richards JH: Determination of intracellular pH by P-31 NMR. J Biol Chem 1973; 248:7276-8
14. McCully KK, Vandenborne K, DeMeirlier K, Posner JD, Leigh JS: Muscle metabolism of track athletes, using 31-P magnetic resonance spectroseopy. Can J Physiol Pharmacol 1992; 70:1353-9
15. Metz CE: Basic principles of ROC analysis. Semin Nucl Med 1978; 8:283-98
16. Kemp GJ, Taylor DJ, Styles P, Radda GK: The production, buffering and efflux of protons in human skeletal muscle during exercise and recovery. NMR Biomed 1993; 6:73-83
17. Bendahan D, Desnuelle C, Vanuxem D, Confort-Gouny S, Figarella-Branger D, Pellissier JF, Kozak-Ribbens G, Pouget J, Serratrice G, Cozzone PJ: 31-P NMR spectroscopy and ergometer exercise test as evidence for muscle oxidative performance improvement with coenzyme Q in mitochondrial myopathies. Neurology 1992; 42:1203-8
18. Lopez JR, Alamo L, Caputo C, Wikinski J, Ledezma D: Intracellular ionized calcium concentration in muscles from humans with malignant hypothermia. Muscle Nerve 1985; 5:355-8
19. Condrescu M, Lopez JR, Medina P, Alamo L: Deficient function of the sarcoplasmic reticulum in patients susceptible to malignant hypothermia. Muscle Nerve 1987; 10:238-41
20. Arnold DL, Matthews PM, Radda GK: Metabolic recovery after exercise and the assessment of mitochondrial function in vivo in human skeletal muscle by means of P-31 NMR, Magn Reson Med 1984; 1:307-15
21. 2+ ATPase deficiency in a patient with an exertional muscle pain syndrome. J Neurol Neurosci Psychiatry 1988; 51:1425-33
22. Fagerlund T, Islander G, Rancley E, Harbitz I, Hange JG, Mokbely E, Berg K: Genetic recombination between malignant hyperthermia and calcium release channel in skeletal muscle. Clin Genet 1992; 41:270-2
23. Levitt RC, Olckers A, Meyers S, Fletcher JE, Rosenberg H, Isaacs H, Meyers DA: Evidence for the localization of a malignant hyperthermia susceptibility locus (MHS2) to huma chromosome 17q. Genomics 1992; 14:562-6
24. Sudbrak R, Procaccio V, Klausnitzer M, Curran JL, Monsieurs K, Van Broeckhoven C, Ellis E, Heytens L, Hartung EL, Kozak-Ribbens G, Heilinger D, Weissenbach J, Lehmann-Horn F, Mueller CL, Deufel T, Stewart AD, Lumardi J: Mapping of a further malignant hyperthermia susceptibility (MHS) locus to chromosome 3ql3.1. Human Genet 1995; 56:684-91
25. Iles DE, Lehmann-Horn F, Scherer SW, Tsui LC, Weghuis DO, Suijkerbuikj RF, Heytens L, Mikala G, Schwartz A, Ellis FR, Stewart AD, Deufel T, Wieringa B: Localization of the gene encoding the α2/γ-suhunits of the L type voltage-dependent calcium channel to chromosome 7q and analysis of the segregation of flanking markers in malignant hyperthermia susceptible families. Hum Mol Genet 1994; 3:969-75
26. Brownell AKW: Malignant hyperthermia: Relationship to other disease. Br J Anaesth 1988; 60:303-8